Form 10-Q · Quarterly report
Xcel Energy 10-Q, filed Jul 30, 2026
- Filed
- CIK
- 0000072903
- Accession no.
- 0000072903-26-000154
Summary
Xcel Energy reported second-quarter 2026 diluted GAAP and ongoing earnings of $0.93 per share, up from $0.75 per share a year earlier, primarily driven by increased recovery of electric infrastructure investments and partially offset by higher financing costs.
Key points
- Xcel Energy's second-quarter 2026 GAAP diluted EPS was $0.93, up from $0.75 in the same period in 2025; six-month GAAP diluted EPS was $1.82 versus $1.59.
- Ongoing diluted EPS was $0.93 for the second quarter and $1.84 for the six months, compared with $0.75 and $1.59 a year earlier.
- Year-to-date ongoing earnings increased at PSCo, NSP-Minnesota, SPS and NSP-Wisconsin, driven largely by higher recovery of electric and natural gas infrastructure investments.
- The Xcel Energy Inc. and Other segment loss narrowed to $(0.02) per share in the second quarter from $(0.06), partly on unrealized gains on investment funds' interests in energy technology companies.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2 — MANAGEMENT’S DISCUSSION Results of Operations The only common equity securities that are publicly traded are common shares of Xcel Energy Inc. Diluted earnings and EPS of each subsidiary discussed below do not represent a direct legal interest in the assets and liabilities allocated to such subsidiary but rather represent a direct interest in our assets and liabilities as a whole. Xcel Energy’s second quarter diluted GAAP and ongoing earnings were $0.93 per share compared with $0.75 per share in the same period in 2025. The change in earnings per share was primarily driven by increased recovery of electric infrastructure investments, partially offset by higher financing costs. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.